- Home
- CULP vs DXR Comparison
CULP vs DXR Comparison
Compare CULP & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CULP | DXR |
|---|---|---|
| Founded | 1972 | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Textiles | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 52.7M | 46.9M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | CULP | DXR |
|---|---|---|
| Price | $4.01 | $13.15 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $25.00 |
| AVG Volume (30 Days) | ★ 24.2K | 5.1K |
| Earning Date | 12-10-2025 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 3.46 |
| EPS | N/A | ★ 0.36 |
| Revenue | ★ $207,391,000.00 | $66,306.00 |
| Revenue This Year | $1.93 | N/A |
| Revenue Next Year | $2.77 | N/A |
| P/E Ratio | ★ N/A | $36.33 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.42 | $6.55 |
| 52 Week High | $5.94 | $14.15 |
Technical Indicators
Market Signals| Indicator | CULP | DXR |
|---|---|---|
| Relative Strength Index (RSI) | 49.15 | 54.58 |
| Support Level | $3.78 | $12.91 |
| Resistance Level | $3.89 | $13.53 |
| Average True Range (ATR) | 0.13 | 0.44 |
| MACD | 0.03 | 0.01 |
| Stochastic Oscillator | 55.56 | 67.68 |
Price Performance
Historical ComparisonAbout CULP Culp Inc.
Culp Inc manufactures, markets mattress fabrics for bedding and upholstery fabrics for residential, commercial, and hospitality furnishings. The company has two operating segments: Mattress fabrics, which generate maximum revenue, and Upholstery fabrics. The mattress fabrics segment manufactures, sources, and sells fabrics and mattress covers to bedding manufacturers. The upholstery fabrics segment develops, sources, manufactures, and sells fabrics to residential, commercial, and hospitality furniture manufacturers. Geographically, it derives key revenue from the United States of America.
About DXR Daxor Corporation
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.